. Recombination between lox66 and lox71 sites produces one inactive lox site and one loxP site (Fig. 1d) , making this integration irreversible 10 . The Floxin vectors also include beta actin (Actb) promoters that reactivate βgeo expression and thus permit pharmacological selection of correct insertions (Fig. 1c,d) .
Integration of Floxin vectors permits expression of defined sequences at the modified locus (Fig. 1c,d ). We illustrate here the production of C-and N-terminally tagged versions of YFG. pFloxin vectors contain a splice acceptor to restore splicing to the endogenous 5′ exons. The pFloxin-YFG-Flag cDNA is spliced so that the inserted sequence is expressed as a fusion with upstream exons from the endogenous promoter. The other Floxin vector, pFloxin-IRES-HA-YFG, contains an internal ribosome entry site (IRES) element to initiate translation of an N-terminally tagged version of YFG. The line YFG IRES-HA-YFG/+ expresses full length HA-YFG under the control of the endogenous promoter and the IRES element.
To date, the BayGenomics and Sanger Institute gene trap efforts have generated 24,149 gene trap cell lines with the pGTLxf and pGTLxr vectors, representing 4,528 individual genes 11 . These Floxin-compatible gene trap alleles are listed in Supplementary Table 1 , and the cell lines are available to the community through the International Gene Trap Consortium (IGTC) database (http://www.genetrap.org/). Here we demonstrate modification of eight genomic loci (Sall4, Suz12, Ofd1, Gli2, Tardbp, Sntb2, Pex14 and Tet1) using gene trap cell lines and the Floxin system. We note that Ofd1 Gt (Ofd1 Gt(RRF427)Byg ; official symbols for all alleles are listed in Supplementary Table 2 ) cells are hemizygous, as the Ofd1 gene is X-linked and the gene trap ESCs are male. Consequently, Ofd1 Gt cells do not produce any Ofd1 protein (Fig. 1e) .
Upon expression of nuclear Cre recombinase in gene trap cells, on average, 45% of colonies screened showed proper excision of the splice acceptor (Supplementary Table 3 ). Revertant cells no longer displayed β-galactosidase activity or neomycin resistance ( Fig. 2a and Supplementary Fig. 1d,e) . Genomic PCR and Southern blot analyses confirmed correct excision of the splice acceptor in revertant cells (Supplementary Fig. 1f,g ).
Using the Floxin strategy, we generated cell lines expressing full-length Ofd1, Suz12, Sall4, Gli2 or Tardbp with C-terminal tags, and lines expressing eGFP at the Sntb2, Pex14 or Tet1 genomic loci. We electroporated revertant lines with the appropriate pFloxin plasmid and a nuclear Cre expression plasmid and selected for βgeo reactivation with G418. On average, 86% of resultant ESC colonies contained the correctly integrated pFloxin construct (Supplementary Table 4 We describe a method for the highly efficient and precise targeted modification of gene trap loci in mouse embryonic stem cells (escs). through the floxin method, gene trap mutations were reverted and new dna sequences inserted using cre recombinase and a shuttle vector, pfloxin. floxin technology is applicable to the existing collection of 24,149 compatible gene trap cell lines, which should enable high-throughput modification of many genes in mouse escs.
Common methods for genetically modifying embryonic stem cells (ESCs) are transgene insertion and homologous recombination. A complementary approach to generating loss-of-function mutations in ESCs is gene trapping 1,2 . Here we describe the gene trap vectors pGTLxf and pGTLxr, which allow postinsertional modification of the trapped locus using an accompanying technology called flanked lox site insertion, or Floxin. By avoiding the most laborious aspects of traditional gene replacement strategies, the Floxin system allows new alleles to be efficiently engineered.
Floxin uses recombination-mediated cassette exchange, a technology previously demonstrated to function robustly in ESCs [3] [4] [5] [6] [7] [8] . To describe this system, we outline mutation, reversion and modification of a generic, autosomal gene of interest (YFG) (Fig. 1) . A pGTLxf or pGTLxr gene trap in an intron of YFG results in expression of a YFG-βgeo fusion protein in the gene trap line with the genotype YFG Gt/+ (Fig. 1a) . βgeo encodes a fusion of β-galactosidase and neomycin resistance. To revert this loss-offunction mutation, transiently expressed Cre excises the 'floxed' splice acceptor, leaving a single lox71 site 9 (Fig. 1b) . In the absence of the splice acceptor, YFG Rev/+ cells lose βgeo expression and reactivate YFG expression.
To permit modification of a gene trap locus, we created pFloxin vectors that contain a lox66 site (Fig. 1c) so that Cre-mediated recombination between the pFloxin lox66 and the genomic lox71 site of revertant cells results in directional insertion of pFloxin (Fig. 2a) . Genomic PCR and Southern blot analyses confirmed integration in Floxin cell lines (Supplementary Figs. 1g, 2a-c) .
Revertant alleles were expressed at wild-type levels in Sall4 Rev/+ and Suz12 Rev/+ cells ( Fig. 2b and Supplementary Fig. 2d ). In contrast, Ofd1 Rev cells expressed less Ofd1 (at the expected size of 110 kDa) than wild-type cells (Fig. 2c) . Molecular analyses indicated that the reduced Ofd1 expression observed in Ofd1 Rev cells was attributable to the use of cryptic splice acceptor sites present in the βgeo cassette (data not shown and Supplementary Fig. 1e ). Ofd1 is essential for the formation of the primary cilium 12 , and wild-type ESCs possessed primary cilia whereas Ofd1 Gt cells did not. Ofd1 Rev cells possessed primary cilia, indicating that reversion of the gene trap mutation restored gene function (Fig. 2d) .
Floxin-inserted alleles were expressed at levels equivalent to the revertant alleles. The tandem affinity purification (TAP)-tagged alleles for both Sall4 Sall4TAP/+ and Suz12 Suz12TAP/+ were expressed at wild-type levels ( Fig. 2b and Supplementary Fig. 2d ). Although Ofd1-Myc protein levels were lower than endogenous Ofd1 levels ( Fig. 2c) , production of Ofd1-Myc was also sufficient to support ciliogenesis (Fig. 2e) , and Ofd1-Myc, like endogenous Ofd1, localized to the centrosome (Fig. 2f) . Suz12-TAP, like endogenous Suz12, localized to the nucleus (Fig. 2g) , and ESC differentiation led to downregulation of endogenous Suz12 and Suz12-TAP to similar extents 13 (Fig. 2h) . Together, these data indicate that Floxin cells produced modified proteins that functioned and were regulated similarly to wild-type proteins.
In addition to tagging endogenous gene products, the Floxin technology can be used to insert exogenous DNA into loci. Sntb2 IRESeGFP/+ , Pex14 IRESeGFP/+ and Tet1 IRESeGFP/+ lines expressed eGFP under the control of endogenous regulatory elements (Supplementary Fig. 2e) .
As the presence of vector sequence may affect normal gene expression, we included FRT sites in the gene trap and Floxin vectors to permit Flp-mediated removal of the Actb promoter and βgeo cassette (Fig. 1a,c and Supplementary Fig. 3a) . We electroporated Ofd1 Ofd1myc or Gli2 Gli2TAP/+ cells with a mouse codon-optimized Flp (Flpo) expression construct 14 and identified cells in which the Actb-βgeo cassette was excised by screening for loss of β-galactosidase activity (Fig. 2a) . We verified correct excision by genomic PCR (Supplementary Fig. 3c ). Removal of vector sequences increased the expression of Ofd1-Myc (Supplementary Fig. 3d ).
To assess whether the genetic manipulations associated with this approach affected ESCs, we performed karyotyping and evaluated pluripotency by three methods. The five Floxin lines evaluated had normal euploid karyotypes (data not shown). All Floxin lines had normal embryonic stem colony and cell morphology (Supplementary Fig. 4a) . Additionally, expression of three regulators of pluripotency, Oct4, Sox2 and Nanog, in Floxin lines was similar to that in wild-type ESCs, and Floxin lines could differentiate into cell types that express markers of embryonic ectoderm, endoderm and mesoderm ( Supplementary  Fig. 4b,c) . Whereas these assays suggest that the Floxin process does not adversely affect ESC pluripotency, we have not systematically evaluated germline competency of Floxin cells. Other studies have shown that three genetic manipulations do not necessarily limit germline transmission 4, 15 .
The system described here enables efficient mutation, reversion and Floxin-mediated engineering of ESC loci. We generated tagged or reporter alleles at eight loci and used the technology to generate varied alleles, study protein localization and analyze dynamics of protein expression (Supplementary Table 5 ). The Floxin strategy has several advantages over other approaches for manipulating the ESC genome. First, unlike homologous recombination, the Floxin strategy does not require cloning of large arms. Second, unlike transgenes, Floxin alleles are created in the native genomic context. Third, each modification causes the presence or absence of βgeo expression, assisting in the selection or identification of the desired cells. Fourth, reversion allows for confirmation that observed cellular phenotypes are due to the gene trap mutation. Fifth, inserted DNA sequences can be expressed either as a direct fusion to upstream exons or as a separate cistron. Sixth, FRT sites allow for removal of the Actb-βgeo cassette, abrogating interference from vector sequences. And last, the Floxin technology is compatible with the extensive collection of 24,149 characterized and validated gene trap lines available to the community.
In addition to the demonstrated application, the Floxin strategy could be used to generate alleles expressing other exogenous 
Accession codes. GenBank: EU916834 (pFloxin), EU916835 (pFloxin-IRES), EU916836 (pFloxin-TAP), GQ357182 (pFloxin-IRES-eGFP) and GU180239 (pFloxin-MCS2-IRES-MCS).
Note: Supplementary information is available on the Nature Methods website. 
Gt/+ (XC030) and XD052 Gt (XD052) were provided by W.C.S. Cells were cultured on 0.1% gelatin in GMEM supplemented with 10% FBS, glutamine, pyruvate, nonessential amino acids, β-mercaptoethanol and leukemia inhibitory factor (LIF). Revertant and Floxin cell lines are available from J.F.R.
Plasmids and vector construction. pGTLxf and pGTLxr gene trap vectors are available from W.C.S.; pFloxin vectors are available from J.F.R. pPGK-NLS-Cre expresses a fusion of the bacteriophage P1 recombinase Cre with a SV40 large T antigen nuclear localization signal 16 . pFloxin vectors were built from the pBluescript backbone by PCR amplification and insertion of an Engrailed2 splice acceptor sequence, SV40 poly(A) signal sequence and, in the case of pFloxin-IRES, an IRES sequence. The tandem stop codons and multiple cloning site polylinker were synthesized as oligonucleotides and ligated into the vectors. All pFloxin constructs were produced in recA1 Stbl2 cells (Invitrogen) according to manufacturer's protocol, except cultures were grown at 37 °C in LB medium. The vector pFloxin-MCS2-IRES-MCS contains two multiple cloning sites and an IRES, allowing insertion of homologous cDNA as well as a reporter regulated by the same promoter.
cDNA constructs and cloning. Suz12 and Sall4 cDNAs were gifts from M. Ramalho-Santos. To make Sall4 Sall4TAP/+ and Suz12 Suz12TAP/+ cell lines, primers were used to amplify and add appropriate restriction sites to exons 2-4 of Sall4, and exons 8-16 of Suz12 (Supplementary Table 6) . The cDNAs were then cloned into pFloxin-TAP, in frame with the TAP tag. Ofd1 cDNA was cloned from RNA of embryonic day (E)11.5 mouse embryos using 1 Step RT-PCR kit (Invitrogen). Additional amplification and addition of the Myc tag was performed with the Expand High Fidelity kit (Roche). QuikChange II XL site-directed mutagenesis kit (Stratagene) was used to repair missense mutations introduced during PCR. Final products were sequenced.
Electroporation and selection. For reversion, 60 µg of pGK-NLSCre DNA was ethanol-precipitated and the pellet was washed 3 times with 70% ethanol. The pellet was dried in tissue culture hood for 30 min at room temperature (20-25 °C) and resuspended in 100 µl calcium-and magnesium-free PBS (pH 7.4) overnight at room temperature. On the morning of electroporation, new medium was added to the gene trap cells grown to 70-90% confluency in a T75 flask. After 3-4 h, cells were trypsinized, counted and washed with PBS. We added 10 7 cells to a chilled electroporation cuvette with DNA and electroporated at 240 V, 500 µF, exponential (GenePulser Xcell; Bio-Rad). Electroporated cells were incubated 20 min at room temperature, and 10 5 cells were split evenly between ten 10-cm plates. Colonies were picked and transferred to a 48-well plate after 3-5 d.
For Floxin, pGK-NLS-Cre and pFloxin DNA were prepared as above. We electroporated revertant cell lines with both DNAs as above, except 10 7 cells were plated evenly between six 10-cm plates.
We began selection with 150-350 µg ml −1 G418 (Invitrogen) 1 d after electroporation, and picked colonies after 6-7 d.
For FLP removal of vector sequence, 120 µg pPGK-FLPo (Addgene) was prepared as above. We electroporated and plated Floxin cell lines as described for reversion above.
-galactosidase activity assays. Galacto-Light Plus System (Applied Biosystems) was used to assay cell lysates from a 24-or a 48-well plate according to manufacturer's protocol.
Quantitative PCR. RNA was extracted from ESCs or embryoid bodies using RNeasy Plus (Qiagen). First strand cDNA synthesis was performed using extracted RNA with iScript (Bio-Rad) or First Strand cDNA Synthesis (Fermentas). Transcript levels were measured in triplicate using a 7300 Realtime PCR machine (Applied Biosystems) and then normalized to Actb amounts.
Antibodies. Antibodies to Ofd1 were generated by Covance by immunizing rabbits with the peptide (H)-CDTYDQK LKTELLKYQLELKDDYI-(NH 2 ) corresponding to amino acids 340-362 of mouse Ofd1. Antibody was used at 1:5,000 for western blotting and 9.2 µg for immunoprecipiation. Other antibodies used were: acetylated tubulin (Sigma T6793) used at 1:1,000, Immunofluorescence and microscopy. For ESC ciliation studies, ESCs were plated on coverslips coated with poly(d-lysine) and 1% Matrigel (BD) and treated with 0.5 mM mimosine (Sigma) overnight to arrest cells. Cells were fixed 5 min in 4% PFA, washed in PBS, and fixed 2-3 min in −20 °C methanol. The cells were then washed in PBS with 0.1% Triton-X 100 (PBST), blocked in 2% BSA in PBST and incubated with primary antibodies in block for 1 h at room temperature. The cells were washed in PBST, incubated with secondary antibodies in block for 30 min at room temperature, and mounted with Vectashield hardset with DAPI (Vector labs). Slides were viewed on Deltavision microscope (Applied Precision) and images were processed with Deltavision and Metamorph (Molecular Devices) software.
For GFP staining, cells were plated on coverslips as above and grown overnight. Cells were fixed 5 min in 4% PFA and stained as above. Slides were viewed on an Axio Observer D1 (Zeiss) microscope and images were processed with Axiovision (Zeiss), ImageJ (NIH) and Metamorph (Molecular Devices) software.
For TAP staining, cells were plated on coverslips as above and grown overnight. The cells were fixed in 100% methanol for 5 min and stained as above. Slides were viewed on Nikon C1 confocal and images were processed with Nikon EZ-C1 software.
For cellular morphology assessment, cells were plated in 6-well plates and viewed on an Axio Observer D1 (Zeiss) microscope. ESC differentiation. ESCs were plated in suspension culture in ultra-low-adherence six-well plates (Corning) at 5 × 10 5 cells per well (differentiation assay to asses Suz12 expression) or 10 6 cells per well in duplicate (pluripotency assessment) to induce embryoid body formation. Suspension medium consisted of 10% FBS, nonessential amino acids, pyruvate, glutamine and β-mercaptoethanol in GMEM and was changed every other day. For the differentiation assay to assess Suz12 expression, protein lysate was collected on 0, 4, 8 and 12 d after initial plating. For pluripotency assessment, RNA was collected 7 d after plating. 
